Are Skin Lesion Analyzers Ready for Prime Time?
While the FDA is proposing to reclassify two class III computer-aided melanoma detection devices as class II devices, most members of its General and Plastic Surgery Devices Panel suggested that such a move would be premature during the Medical Devices Advisory Committee meeting on Friday. According to the FDA, reclassification of the MelaFind and Nevisense […]